Physician profile
Jean E Leconte
NPI 1699850602
$2,041.95
in general payments reported to CMS, 2019-2025
8 companies · $290 in 2025
The $290 reported for 2025 was more than what 82% of General Practice (Dentist) providers received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $75.79 · 2020: $108 · 2021: $71.61 · 2022: $1,372 · 2023: $49.94 · 2024: $75.04 · 2025: $290.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $294 · Education: $120 · Gift: $0.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $293.74 |
| Education | $120.45 |
| Gift | $0.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dentsply Sirona INC | $1,315.37 | 2019-2024 | Waveone Gold Conform Fit, Implant Dentistry |
| Align Technology, INC. | $312.81 | 2019-2025 | Invisalign |
| Implant Direct Sybron International LLC | $132.88 | 2019-2022 | |
| Orapharma, A Division of Bausch Health US, LLC | $116.73 | 2020-2022 | |
| Straumann USA LLC | $85.69 | 2025 | |
| Philips North America LLC | $35.59 | 2019-2022 | |
| Gc America INC. | $31.31 | 2021-2023 | Gc Fuji |
| National Dentex LLC | $11.57 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jean Leconte listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.